Posted On: 05/20/2014 2:41:55 PM
Post# of 63724
$DNDN upturn gap. $2.34
Treatment with PROVENGE® (sipuleucel-T) Induces
Antigen Spread Associated with Overall Survival Benefits
In Advanced Prostate Cancer 2014-05-20 08:00 ET
News Release
Website
Consensus
10-Q 5/8/14
O/S shares 159,965,114
recent trades & PRs
Stockwatch
% Buy Opinion (composite)
Treatment with PROVENGE® (sipuleucel-T) Induces
Antigen Spread Associated with Overall Survival Benefits
In Advanced Prostate Cancer 2014-05-20 08:00 ET
News Release
Website
Consensus
10-Q 5/8/14
O/S shares 159,965,114
recent trades & PRs
Stockwatch
% Buy Opinion (composite)
(0)
(0)Scroll down for more posts ▼
